Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers

Clinical Cancer Research

Volumn 9, Issue 16 I, 2003, Pages 5835-5841

  Mao, Jenny T ^a   Roth, Michael D ^a   Serio, Kenneth J ^b   Baratelli, Felicita ^a   Zhu, Li ^a   Holmes, E Carmack ^a   Strieter, Robert M ^a   Dubinett, Steven M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; BIOLOGICAL MARKER; CALCIMYCIN; CALCIUM IONOPHORE; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; MALE; PHENOTYPE; PILOT STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING;

AGED; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CALCIMYCIN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEASIBILITY STUDIES; FEMALE; HUMANS; INTERLEUKIN-10; IONOPHORES; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PILOT PROJECTS; PYRAZOLES; SMOKING; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0346734287     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Rioux, N., and Castonguay, A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res., 58: 5354-5360, 1998.
2. Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342: 1946-1952, 2000.
3. Herschman, H. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996.
4. Lipsky, P. E., and Isakson, P. C. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J. Rheumatol., 24: 9-14, 1997.
5. Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smiith, W. G., Isakson, P. C., and Seibert, K. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA, 91: 3228-3232, 1994.
6. Murata, H., Kawano, S., Tsuji, S., Tsuji, M., Sawaoka, H., Kimura, Shiozaki, H., and Hori, M. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am. J. Gastroenterol., 94: 451-455, 1994.
7. Dohadwala, M., Luo, J., Zhu, L., Lin, Y., Dougherty, G. J., Sharma, S., Huang, M., Pold, M., Batra, R. K., and Dubinett, S. M. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J. Biol. Chem., 276: 20809-20812, 2001.
8. Masferrer, J. L., Koki, A., and Seibert, K. COX-2 inhibitors. A new class of antiangiogenic agents. Ann. N. Y. Acad. Sci., 889: 84-86, 2000.
9. Herschman, H. R. Cancer Metastasis Rev., Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. 13: 241-256, 1994.
10. Hida, T., Kozaki, K., Muramatsu, H., Masuda, A., Shimizu, S., Mitsudomi, T., Sugiura, T., Ogawa, M., and Takahashi, T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res., 6: 2006-2011, 2000.
11. Huang, M., Stolina, M., Sharma, S., Mao, J., Zhu, L., Miller, P., Wollman, J., Hershman, H., and Dubinett, S. M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58: 1208-1216, 1998.
12. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
13. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
14. Hosomi, Y., Yokose, T., Hirose, Y., Nakajima, R., Nagai, K., Nishiwaki, Y., and Ochiai, A. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer, 30: 73-81, 2000.
15. 2 and to express cyclooxygenase-2. J. Clin. Investig., 95: 1861-1868, 1995.
16. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol., 157: 5512-5520, 1996.
17. 2, promote Th2 responses. Adv. Exp. Med. Biol., 417: 363-367, 1997.
18. Sharma, S., Stolina, M., Yang, S. C., Baratelli, F., Lin, J. F., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., Dohadwala, M., Batra, R. K., and Dubinett, S. M. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin. Cancer Res., 9: 961-968, 2003.
19. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol., 168: 2255-2263, 2002.
20. Swisher, S. G., Kiertscher, S. M., Golub, S. H., Holmes, E. C., and Roth, M. D. Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes. Am. J. Respir. Cell Mol. Biol., 8: 486-492, 1993.
21. Roth, M. D., and Golub, S. H. Human pulmonary macrophages utilize prostaglandins and transforming growth factor β1 to suppress lymphocyte activation. J. Leukocyte Biol., 53: 366-371, 1993.
22. Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., Rogers, R. S., Rogier, D. J., Yu, S. S., Anderson, G. D., Burton, E. G., Cogburn, J. N., Gregory, S. A., Koboldt, C. M., Perkins, W. E., Seibert, K., Veenhuizen, A. W., Zhang, Y. Y., and Isakson, P. C. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J. Med. Chem., 40: 1347-1365, 1997.
23. Barbers, R. G., Gong, H., Jr., Tashkin, D. P., Oishi, J., and Wallace, J. M. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am. Rev. Respir. Dis., 135: 1271-1275, 1987.
24. Ryder, M. I., Saghizadeh, M., Ding, Y., Nguyen, N., and Soskolne, A. Effects of tobacco smoke on the secretion of interleukin-1β, tumor necrosis factor-α, and transforming growth factor-β from peripheral blood mononuclear cells. Oral Microbiol. Immunol., 17: 331-336, 2002.
25. Altorki, N. K., Keresztes, R. S., Port, J. L., Libby, D. M., Korst, R. J., Flieder, D. B., Ferrara, C. A., Yankelevitz, D. F., Subbaramaiah, K., Pasmantier, M. W., and Dannenberg, A. J. Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. J. Clin. Oncol., 21: 2645-2650, 2003.
26. Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., Lee, J. C., and Dubinett, S. M. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol., 164: 361-370, 2000.
27. 2. J. Exp. Med., 180: 2365-2370, 1994.
28. Igietseme, J. U., Ananaba, G. A., Bolier, J., Bowers, S., Moore, T., Belay, T., Eko, F. O., Lyn, D., and Black, C. M. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Thlinduction: potential for cellular vaccine development. J. Immunol., 164: 4212-4219, 2000.
29. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., and O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol., 19: 683-765, 2001.
30. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., and O'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Thl cells. J. Immunol., 146: 3444-3451, 1991.
31. + T cells. J. Immunol., 160: 3188-3193, 1998.
32. Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., and Granstein, R. D. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol., 154: 1280-1286, 1995.
33. Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A., and Nickoloff, B. J. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol., 154: 2668-2677, 1995.
34. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J. E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med., 174: 915-924, 1991.
35. Kraal, G., Broug, E., Thepen, T., Van Iwaarden, J. F., and Persoons, J. H. A. The role of alveolar macrophages in pulmonary immune function. In: M. F. Lipscomb and S. W. Russell (eds.), Lung Macrophages and Dendritic Cells in Health Disease, pp. 203-220. New York: Marcel Dekker Inc., 1997.
36. Yan, Z., Subbaramniah, K., Camilli, T., Zhang, F., Tanabe, T., McCaffrey, T. A., Dannenberg, A. J., and Weksler, B. B. Benzo-[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-κB. J. Biol. Chem., 275: 4949-4955, 2000.
37. Kelley, D. J., Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., Ramonetti, J. T., and Dannenberg, A. J. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis (Lond.), 18: 795-799, 1997.
38. Monick, M. M., and Hunninghake, G. W. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur. Respir. J., 20: 210-222, 2002.
39. Therriault, M. J., Proulx, L. I., Castonguay, A., and Bissonnette, E. Y. Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages. Clin. Exp. Immunol., 132: 232-238, 2003.
40. Kim, H-J., Kim, K-W., Yu, B-P., and Chung, H-Y. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic. Biol. Med., 28: 683-692, 2000.